In Q2FY23, Aarti’s revenue grew 34.2% YoY/4.6% QoQ to INR 16,850 mn. During the quarter, the demerger of Pharma Business from Aarti Industries into its wholly owned subsidiary Aarti Pharmalabs Limited was approved by National Company Law Tribunal (NCLT), on September 21, 2022